Trial Profile
AEROSOLIC TREATMENT OF ACUTE AND RECURRENT RHINOSINUSITIS DURING INTERCRITICAL STAGES : SINGLE BLIND CLINICAL STUDY, N-ACETYLCISTEIN VS AMBROXOL, ASSOCIATED WITH CORTISONE THERAPY.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 23 Apr 2012
Price :
$35
*
At a glance
- Drugs Acetylcysteine (Primary) ; Ambroxol; Flunisolide
- Indications Rhinosinusitis
- Focus Therapeutic Use
- Sponsors Zambon SpA
- 09 Aug 2011 New trial record